Express News | Celularity Presents Data On T-Cell Therapy Platform At ASCO Annual Meeting; PT-CD16VS Shows Potent Activity And Potential For Combination With Monoclonal Antibodies To Target Multiple Cancers
Express News | Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
Express News | Celularity Granted European Patent EP3957315 For Treatment Of Diabetic Peripheral Neuropathy Using Placental Cells
Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy
Celularity Inc. to Host Investor and Analyst Research & Development Day
Express News | Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
Celularity Abstract "Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials" Accepted at ORS Tendon Conference 2024
Express News | Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&a Reductions and Manufacturing Ramp for Advanced Biomaterial Products
Celularity To Present Data Showing Senescent Cell Elimination By Off-The-Shelf Natural Killer Cells Derived From Human Placental Cells
Celularity Receives Healthcare Common Procedure Coding System Q Code Approval From The U.S. Centers For Medicare & Medicaid Services For Biovance 3L
Express News | Celularity Submits Request To US FDA For Orphan Drug Designation For PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy
Celularity CEO to Present on Cell Therapy's Potential to Improve Longevity at 2024 ABUNDANCE Summit
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Stock Market Resilience: Celularity Inc's (CELU) Remarkable Turnaround
Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress
Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived From Human Placental Cells
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
There's No Escaping Celularity Inc.'s (NASDAQ:CELU) Muted Revenues Despite A 29% Share Price Rise
Celularity To Carry Out 1-for-10 Reverse Stock Split On February 29th, 2024
Workday, Domino's And 3 Stocks To Watch Heading Into Monday